1. Bristol-Myers Squibb

Renaissance's biggest holding is its $1.66 billion stake in Bristol-Myers Squibb, a pharmaceuticals giant that makes medicines to treat cancer, HIV/AIDS, cardiovascular disease, diabetes, and other ailments.

Federal regulators approved the company's proposed $74 billion takeover of biotech firm Celgene this month.